0001214659-21-002803.txt : 20210305 0001214659-21-002803.hdr.sgml : 20210305 20210305165019 ACCESSION NUMBER: 0001214659-21-002803 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210303 FILED AS OF DATE: 20210305 DATE AS OF CHANGE: 20210305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAGUSA ROBERT P CENTRAL INDEX KEY: 0001222644 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 21719169 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-51731.xml PRIMARY DOCUMENT X0306 4 2021-03-03 0001581280 Twist Bioscience Corp TWST 0001222644 RAGUSA ROBERT P C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 true false false false Common Stock 2021-03-03 4 M false 10588 30.41 A 12486 D Common Stock 2021-03-03 4 S false 2299 132.1549 D 10187 D Common Stock 2021-03-03 4 S false 6519 133.0980 D 3668 D Common Stock 2021-03-03 4 S false 1770 134.0424 D 1898 D Director Stock Option (right to buy) 30.41 2021-03-03 4 M false 10588 0 D 2029-07-22 Common Stock 10588 0 D Represents the weighted average sales price per share. The shares sold at prices ranging from $131.44 to $132.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $132.59 to $133.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Represents the weighted average sales price per share. The shares sold at prices ranging from $133.61 to $134.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. 100% of the shares subject to the option vested and became exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date. /s/ William Solis, as Attorney-in-Fact for Robert Ragusa 2021-03-05